TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31953844

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MF)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mindlessness meditation (ML)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 24
Study: 30452125

Group type: EXPERIMENTAL
Intervention: TIVA (propofol and remifentanil infusion)
Number of subjects: 80

Group type: COMPARATOR
Intervention: DES (desflurane inhalation and remifentanil infusion)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: TIVA
Number of subjects: 80
Study: 28086244

Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 84

Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 84
Study: 26279108

Group type: EXPERIMENTAL
Intervention: Focused cardiac ultrasound (FCU) assessment of inferior vena cava (IVC) size and collapsibility.
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: FCU IVC imaging categorization (normal, intermediate, plethoric IVCs).
Number of subjects: 95

Group type: COMPARATOR
Intervention: Clinical bedside assessment of volume status.
Number of subjects: 95
Study: 23262204

Group type: EXPERIMENTAL
Intervention: Combination of temsirolimus (25 mg IV weekly) and bevacizumab (10 mg/kg every other week)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combination of temsirolimus and bevacizumab
Number of subjects: 49
Study: 21251162

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 1040
Study: 19692044

Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone (experimental group 2)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Emollient cream (placebo group 1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Topical triamcinolone (nonblinded treatment for nonresponders)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 63
Study: 16469977

Group type: EXPERIMENTAL
Intervention: High-protein breakfast (HP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-carbohydrate breakfast (HC)
Number of subjects: 15
Study: 14763724

Group type: EXPERIMENTAL
Intervention: Water exercise programme (2 sessions per week, 1 hour duration)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Water exercise programme
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (monthly education material and quarterly telephone calls)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study: 10707876

Group type: EXPERIMENTAL
Intervention: TTV-A primer set
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: TTV-B primer set
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Either/both primer sets
Number of subjects: 171

Group type: COMPARATOR
Intervention: Demographic, biochemical, virologic, and histologic scores
Number of subjects: 171
Study: 9492396

Group type: EXPERIMENTAL
Intervention: Composite stimulation package (STIM)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Nutritional management (NUT)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control group from high socioeconomic status (Control I)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control group from low socioeconomic status (Control II)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Community study interventions (STIM or NUT)
Number of subjects: 432
Study: 8366464

Group type: EXPERIMENTAL
Intervention: Bulimics with depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bulimics without depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depressed patients without bulimia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depressed patients with bulimia
Number of subjects: 0
Study: 3019810

Group type: EXPERIMENTAL
Intervention: 400 mg/day mebeverine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 15 g/day wheat bran
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 31648665

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine 2% with epinephrine 1:100,000
Number of subjects: 65

Group type: COMPARATOR
Intervention: Unbuffered lidocaine 2% with epinephrine 1:100,000
Number of subjects: 65
Study: 28107891

Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive behavioral stress management (T-CBSM), N=56
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Live cognitive behavioral stress management (L-CBSM), N=44
Number of subjects: 100
Study: 26108771

Group type: EXPERIMENTAL
Intervention: Protective appendicostomy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional ileostomy
Number of subjects: 74
Study: 23184666

Group type: EXPERIMENTAL
Intervention: Anagrelide (1 mg) with food/caffeine (standardized breakfast including two cups of coffee)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Anagrelide (1 mg) in a fasted state
Number of subjects: 35
Study: 21849264

Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg weekly
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 18381881

Group type: EXPERIMENTAL
Intervention: Off-pump bypass surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional bypass grafting
Number of subjects: 0
Study: 16522932

Group type: EXPERIMENTAL
Intervention: Gamma-cyclodextrin (GCD)
Number of subjects: 32
Study: 14528202

Group type: EXPERIMENTAL
Intervention: Monopolar coagulation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional treatment (combination heat probe coagulation and injection therapy)
Number of subjects: 99
Study: 10928231

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8826542

Group type: EXPERIMENTAL
Intervention: 15 mg d-amphetamine (AMP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1418277

Group type: EXPERIMENTAL
Intervention: Etomidate (Hypnomidate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone (Trapanal)
Number of subjects: 0
Study: 3908332

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 20
Study: 29166771

Group type: EXPERIMENTAL
Intervention: Yoga (16 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Yoga (8 weeks after crossover)
Number of subjects: 90
Study: 28719494

Group type: EXPERIMENTAL
Intervention: Hockey FIT (intervention group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-list control (comparator group)
Number of subjects: 80
Study: 27116867

Group type: EXPERIMENTAL
Intervention: KinesioTaping
Number of subjects: 60
Study: 23587660

Group type: EXPERIMENTAL
Intervention: Korean pear juice
Number of subjects: 14
Study: 20456545

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate + red-light
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo + red-light
Number of subjects: 48
Study: 18476313

Group type: EXPERIMENTAL
Intervention: Brief motivational tobacco intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Brief advice/care as usual
Number of subjects: 74
Study: 16581897

Group type: EXPERIMENTAL
Intervention: Open suctioning method
Number of subjects: 18

Group type: COMPARATOR
Intervention: Closed suctioning method
Number of subjects: 18
Study: 15362251

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Estrogen and progesterone therapy
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Thyroid therapy
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Docosahexanoic acid
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 7
Study: 11687774

Group type: EXPERIMENTAL
Intervention: High intensity physical activity (75% VO2max)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Light intensity physical activity (45% VO2max)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Moderate intensity physical activity (60% VO2max)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Zero resistance (control)
Number of subjects: 21
Study: 9137847

Group type: EXPERIMENTAL
Intervention: Divalproex sodium 500 mg
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Divalproex sodium 1000 mg
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Divalproex sodium 1500 mg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 7933515

Group type: EXPERIMENTAL
Intervention: Multipurpose pulmonary artery catheter (PAC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: A-V paceport PAC
Number of subjects: 20
Study: 3137036

Group type: EXPERIMENTAL
Intervention: 400 mg pefloxacin b.i.d.
Number of subjects: 42

Group type: COMPARATOR
Intervention: 160/800 mg cotrimoxazole b.i.d.
Number of subjects: 42
Study: 29901829

Group type: EXPERIMENTAL
Intervention: Self-management barriers (measured by PRISM; scaled 1 to 5)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Denial of Disease and Its Consequences
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Regimen Pain and Bother
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Understanding and Organizing Care
Number of subjects: 267
Study: 28005920

Group type: EXPERIMENTAL
Intervention: Vita Mamba (fortified peanut butter snack) and deworming
Number of subjects: 321

Group type: COMPARATOR
Intervention: Control group (deworming only)
Number of subjects: 321
Study: 25100424

Group type: EXPERIMENTAL
Intervention: Proactive care smoking cessation intervention
Number of subjects: 2271

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2271
Study: 23056012

Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 21280316

Group type: EXPERIMENTAL
Intervention: Serum CA-125 levels measured by electrochemiluminescence immunization assay
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum CA-125 levels
Number of subjects: 200
Study: 18461609

Group type: EXPERIMENTAL
Intervention: Adefovir/lamivudine combination therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Adefovir monotherapy
Number of subjects: 8
Study: 15855323

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12648318

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin C (placebo)
Number of subjects: 0
Study: 11204387

Group type: EXPERIMENTAL
Intervention: Port-Access mitral valve surgery (group A, n=14)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Modified technique for Port-Access mitral valve surgery (group B, n=17)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Overall results of Port-Access mitral valve surgery
Number of subjects: 31
Study: 8867431

Group type: EXPERIMENTAL
Intervention: Gadoteridol (0.1 mmol/kg bodyweight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gadoteridol (0.3 mmol/kg bodyweight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gadoteridol (0.1 and 0.3 mmol/kg bodyweight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 20
Study: 1506600

Group type: EXPERIMENTAL
Intervention: Cardiovasoprotective diet
Number of subjects: 463

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 463
Study: 6493883

Group type: EXPERIMENTAL
Intervention: Experimental group received information on burn prevention, including hot water heater settings and smoke detectors.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group received information on nutrition, dental care, safety in the car and home, child development, child rearing, illness management, and immunizations.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Experimental group regarding operational smoke detectors.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group regarding operational smoke detectors.
Number of subjects: 58
Study: 31525928

Group type: EXPERIMENTAL
Intervention: Photodissociation at 210 nm
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Photodissociation at 201 nm
Number of subjects: 2
Study: 29443767

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride 0.5 mg/kg + flurbiprofen axetil 150 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride 0.75 mg/kg + flurbiprofen axetil 150 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride 1.0 mg/kg + flurbiprofen axetil 150 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 26714442

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 mcg/kg (Group L)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2 mcg/kg (Group H)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Second oral dose chloral hydrate 25 mg/kg (Group C)
Number of subjects: 150
Study: 25146587

Group type: EXPERIMENTAL
Intervention: Decision support package (information booklet and trained physiotherapists)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Care as usual (control arm)
Number of subjects: 148
Study: 22983273

Group type: EXPERIMENTAL
Intervention: Retropubic midurethral sling (RMUS)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Transobturator midurethral sling (TMUS)
Number of subjects: 597
Study: 20409302

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine
Number of subjects: 536

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 536
Study: 18707985

Group type: EXPERIMENTAL
Intervention: High-bolus dose tirofiban (n=491)
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo (n=493)
Number of subjects: 984
Study: 16372826

Group type: EXPERIMENTAL
Intervention: Prulifloxacin 600mg administered orally
Number of subjects: 27
Study: 12791229

Group type: EXPERIMENTAL
Intervention: Guggul (Commiphora mukul)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fenugreek (Trigonella foenum-graecum)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Red yeast rice
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Artichoke (Cynara scolymus)
Number of subjects: 25
Study: 10594798

Group type: EXPERIMENTAL
Intervention: Cyclosporine plus low-dose prednisone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 49
Study: 9592327

Group type: EXPERIMENTAL
Intervention: Intensive infection with MSOF
Number of subjects: 68

Group type: COMPARATOR
Intervention: MSOF not combined with DIC
Number of subjects: 68

Group type: COMPARATOR
Intervention: MSOF combined with DIC
Number of subjects: 68
Study: 1649720

Group type: EXPERIMENTAL
Intervention: Luteal phase (days 18-26)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Follicular phase (days 2-8)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both phases
Number of subjects: 11
Study: 3935120

Group type: EXPERIMENTAL
Intervention: Glibenclamide (5 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chlorpropamide (250 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.5-10 mg daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chlorpropamide (125-500 mg daily)
Number of subjects: 11
Study: 31473979

Group type: COMPARATOR
Intervention: Conventional antipsychotics
Number of subjects: 38

Group type: COMPARATOR
Intervention: Atypical antipsychotics
Number of subjects: 38
Study: 29590326

Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Live (ZV)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study: 26110349

Group type: EXPERIMENTAL
Intervention: Beta-Alanine (BA) supplementation (800 mg + 8 g dextrose)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (PLA) (8 g dextrose)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Beta-Alanine (BA) supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 22
Study: 24650125

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (dexamethasone, gabapentin, ibuprofen, paracetamol)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia
Number of subjects: 180

Group type: COMPARATOR
Intervention: Traditional morphine and paracetamol regimen
Number of subjects: 180
Study: 22288671

Group type: EXPERIMENTAL
Intervention: Combination therapy (dipyrone 600 mg, isometheptene 60 mg, caffeine 60 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Paracetamol 1000 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 84
Study: 20437207

Group type: EXPERIMENTAL
Intervention: Partially hydrogenated soybean oil (PHSO diet)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Palm stearin (PST diet)
Number of subjects: 41
Study: 23111655

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (empty gap)
Number of subjects: 21
Study: 15818745

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pentaerythritol tetranitrate (PTN)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Morphine associated with GTN
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Morphine associated with ISDN
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Morphine associated with PTN
Number of subjects: 67
Study: 12421266

Group type: COMPARATOR
Intervention: Schedule A: one dose at 0, 1, and 6 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Schedule B: one dose at 0, 10, and 21 days
Number of subjects: 40
Study: 9658362

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mimic therapeutic touch (mimic TT)
Number of subjects: 20
Study: 7865912

Group type: EXPERIMENTAL
Intervention: Polyclonal RATS (n = 26)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Monoclonal OKT3 (n = 29)
Number of subjects: 55
Study: 2593767

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) administered intravenously
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline administered intravenously
Number of subjects: 8
Study: 29695772

Group type: EXPERIMENTAL
Intervention: Self-monitoring device for daily salt intake
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (no self-monitoring device)
Number of subjects: 158
Study: 28545917

Group type: EXPERIMENTAL
Intervention: RYGB patients receiving oral antibiotics
Number of subjects: 186

Group type: COMPARATOR
Intervention: Controls receiving oral antibiotics
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: RYGB patients receiving fluoroquinolones or sulfonamides
Number of subjects: 186
Study: 25081390

Group type: EXPERIMENTAL
Intervention: NY‐ESO‐1 ISCOMATRIX followed by recombinant fowlpox virus encoding full length NY‐ESO‐1 (rF‐NY‐ESO‐1)
Number of subjects: 39

Group type: COMPARATOR
Intervention: NY‐ESO‐1 ISCOMATRIX alone
Number of subjects: 39
Study: 24091318

Group type: EXPERIMENTAL
Intervention: Standard fortification (3 g/kg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate fortification (3.3 g/kg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggressive fortification (3.6 g/kg/d)
Number of subjects: 0
Study: 21962415

Group type: EXPERIMENTAL
Intervention: Teach to Goal (TTG) educational and behavioral support program with 5 to 8 telephone counseling sessions over 1 month
Number of subjects: 605

Group type: COMPARATOR
Intervention: Brief Educational Intervention (BEI) - 1 hour educational intervention
Number of subjects: 605
Study: 18248158

Group type: EXPERIMENTAL
Intervention: Active laser therapy (LLLT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 20
Study: 17361591

Group type: EXPERIMENTAL
Intervention: Physical training (PT) for 48±6.4 months at 70% of maximal heart rate
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group without physical training
Number of subjects: 230
Study: 12728782

Group type: EXPERIMENTAL
Intervention: Family interventions for family caregiving of elders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family interventions for childhood chronic illness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family interventions for spouse involvement in chronic adult illnesses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family interventions for health promotion/disease prevention
Number of subjects: 0
Study: 11012498

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 25 microg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 25 microg and ropivacaine 2.5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 25 microg and bupivacaine 2.5 mg
Number of subjects: 60
Study: 8994314

Group type: EXPERIMENTAL
Intervention: Combined hepatitis A and B vaccine (3 doses of 1 ml each, containing at least 720 ELISA Units of HAV antigen and 20 micrograms of recombinant HBsAg, administered at 0, 1, and 6 months)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined hepatitis A and B vaccine
Number of subjects: 150
Study: 1427652

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon-alpha alone (5 million units/m2 three times per week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Combination therapy with lymphoblastoid interferon-alpha and levamisole (150 mg three times per week)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon-alpha alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Combination therapy with lymphoblastoid interferon-alpha and levamisole
Number of subjects: 45
Study: 3880877

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel administered intracervically
Number of subjects: 103

Group type: COMPARATOR
Intervention: Demoxytocin buccal tablets
Number of subjects: 103
Study: 31135822

Group type: EXPERIMENTAL
Intervention: Accelerated approval drugs pending confirmatory data
Number of subjects: 85

Group type: COMPARATOR
Intervention: Drugs with regular approval
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Overall response rate (RR)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Complete response rate
Number of subjects: 85